Daron G Ferris1, Jennifer L Waller, Ashley Owen, Jozette Smith. 1. Gynecologic Cancer Prevention Center, Departments of Family Medicine and Obstetrics and Gynecology, Medical College of Georgia, Augusta, GA 30912, USA. dferris@mcg.edu
Abstract
OBJECTIVE: To determine midadult (age, > or =25 years) women's attitudes about receiving the prophylactic human papillomavirus (HPV) vaccine. MATERIALS AND METHODS: Four hundred seventy-two women 25 years or older completed a 46-question survey, read an educational sheet about HPV and HPV vaccines, and then completed a 23-item survey. Frequency data were reported, and interventional effects measured by Bowker test of symmetry. RESULTS: After educational intervention, 50% of mid-adult women wanted to receive the vaccine, and 34.3% were undecided. A desire to be healthy (48.9%), prevent cervical cancer (42.8%), and fear of cervical cancer (35.8%) were the most common reasons for wanting the vaccine. The main reasons for not wanting the vaccine included being in a monogamous relationship (29.5%), not being at risk for acquiring HPV (15.0%), and practicing safe sex (10.8%). CONCLUSIONS: Midadult women have a high level of acceptance for the HPV vaccine. Our findings help support future implementation of the vaccine in this catch-up population of receptive women.
OBJECTIVE: To determine midadult (age, > or =25 years) women's attitudes about receiving the prophylactic human papillomavirus (HPV) vaccine. MATERIALS AND METHODS: Four hundred seventy-two women 25 years or older completed a 46-question survey, read an educational sheet about HPV and HPV vaccines, and then completed a 23-item survey. Frequency data were reported, and interventional effects measured by Bowker test of symmetry. RESULTS: After educational intervention, 50% of mid-adult women wanted to receive the vaccine, and 34.3% were undecided. A desire to be healthy (48.9%), prevent cervical cancer (42.8%), and fear of cervical cancer (35.8%) were the most common reasons for wanting the vaccine. The main reasons for not wanting the vaccine included being in a monogamous relationship (29.5%), not being at risk for acquiring HPV (15.0%), and practicing safe sex (10.8%). CONCLUSIONS: Midadult women have a high level of acceptance for the HPV vaccine. Our findings help support future implementation of the vaccine in this catch-up population of receptive women.
Authors: Mack T Ruffin; Erinn M Hade; Melissa R Gorsline; Cecilia R DeGraffinreid; Mira L Katz; Sarah C Kobrin; Electra D Paskett Journal: Vaccine Date: 2012-06-27 Impact factor: 3.641
Authors: Orkun Çetin; Fatma Ferda Verit; Seda Keskin; Ali Galip Zebitay; Ayşegül Deregözü; Taner Usta; Oğuz Yücel Journal: Turk Pediatri Ars Date: 2014-06-01
Authors: Jennifer D Allen; Gloria D Coronado; Rebecca S Williams; Beth Glenn; Cam Escoffery; Maria Fernandez; Raegan A Tuff; Katherine M Wilson; Patricia Dolan Mullen Journal: Vaccine Date: 2010-04-20 Impact factor: 3.641